Samaritan Health Initiatives

Samaritan Health Initiatives is a private U.S. health care policy consultancy led by former FDA Commissioner and former National Cancer Institute Director Andrew C. von Eschenbach. Public biographies and company directory listings describe it as a health care services or policy consulting organization rather than a drug-development biotech or pharmaceutical company. The company appears to operate from Texas and is associated with advisory, policy, and innovation work in healthcare. No evidence was found of a therapeutic product pipeline, proprietary drug platform, clinical-stage assets, or manufacturing operations. For a biotech analyst, this entity is best understood as a healthcare advisory/consulting company with leadership ties to oncology, FDA policy, and health innovation rather than as an operating therapeutics developer.